Align Technology Set to Reveal Q4 and 2024 Financial Results
January 2, 2025 - 18:21
TEMPE, Ariz., January 02, 2025—Align Technology, Inc., a prominent player in the global medical device industry, has announced its plans to disclose its financial results for the fourth quarter and the entire year of 2024. The results will be made available on Wednesday, February 5, 2025, following the close of market trading.
The announcement is highly anticipated by investors and industry analysts alike, as Align Technology continues to lead the market with its innovative products, including the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software tailored for digital orthodontics and restorative dentistry.
The financial results will be released at 4:00 p.m. ET (2:00 p.m. MT), providing insight into the company's performance and strategic direction. Stakeholders are eager to assess how Align Technology navigated the challenges and opportunities in the medical device sector throughout the past year.
MORE NEWS
June 8, 2025 - 04:39
Rethinking AI: HKUST Scientist Compares It to Climate ChangeIn a recent discussion, De Kai, a prominent scientist from HKUST, presented a compelling perspective on artificial intelligence, likening its impact to that of climate change rather than viewing it...
June 7, 2025 - 22:42
Adapting to the Illinois Prairie: A Technological TransformationSettlers arriving in Illinois faced a stark contrast to the dense forests they were accustomed to. Having journeyed from the Atlantic seaboard through regions like Virginia, Kentucky, and Tennessee...
June 7, 2025 - 01:29
The Growing Role of Artificial Intelligence in FilmmakingArtificial Intelligence’s use in filmmaking is growing, showcasing its potential to revolutionize the industry. Recent film festivals have highlighted innovative projects that leverage AI...
June 6, 2025 - 03:10
Revolutionary Soft Robotics Set to Transform Artificial Heart TechnologyThe Hybrid Heart, an innovative soft robotic total artificial heart, represents a significant advancement in the treatment of end-stage heart failure. This groundbreaking technology focuses on...